Piramal Phytocare Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
- Paid Up Capital ₹ 25.96 Cr
- Company Age 23 Year, 7 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 75.00 Cr
- Revenue Growth 4.74%
- Profit Growth 63.34%
- Ebitda 66.88%
- Net Worth -46.55%
- Total Assets -1.93%
About Piramal Phytocare
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L73100MH2001PLC132523
- Company No.
132523
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Jun 2001
- Date of AGM
05 Aug 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
What products or services does Piramal Phytocare Limited offer?
Piramal Phytocare Limited offers a wide range of products and services, including Health Conditions, Cold & Cough, Menopause, Mental Wellness, Piles, Fissures & Fistula.
Who are the key members and board of directors at Piramal Phytocare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maneesh Sharma  | Company Secretary | 22-Jul-2015 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rashida Najmi | Director | 12-Apr-2017 | Current |
| Gautam Doshi | Director | 01-Apr-2008 | Current |
| Navnitlal Bhatia | Director | 02-Feb-2012 | Current |
| Rajesh Laddha | Director | 02-Feb-2012 | Current |
Financial Performance of Piramal Phytocare.
Piramal Phytocare Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 4.74% increase. The company also saw a substantial improvement in profitability, with a 63.34% increase in profit. The company's net worth observed a substantial decline by a decrease of 46.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Piramal Phytocare?
In 2019, Piramal Phytocare had a promoter holding of 56.08% and a public holding of 43.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sun Pharma Laboratories LimitedGautam Doshi is a mutual person
Sun Pharmaceutical Industries LimitedGautam Doshi is a mutual person
Steel Infra Solutions Private LimitedRajesh Laddha is a mutual person
Aditya Birla Sun Life Insurance Company LimitedManeesh Sharma is a mutual person
Piramal Enterprises LimitedGautam Doshi is a mutual person
- Piramal Capital & Housing Finance Limited
Gautam Doshi is a mutual person
Charges (Loans)
₹0
₹75.00 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 75.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Oct 2008 | Hdfc Bank Limited | ₹75.00 Cr | Satisfied |
How Many Employees Work at Piramal Phytocare?
Unlock and access historical data on people associated with Piramal Phytocare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Piramal Phytocare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Piramal Phytocare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
